PDE4A and chronic obstructive pulmonary disease: Although roflumilast influences many in vitro functions in the human cells involved in COPD (Hatzelmann et al., 2010; Buenestado et al., 2012; Buenestado et al., 2013), the PDE4 inhibitors’ anti-inflammatory effects on human bronchial explants have not previously been assessed.